表紙
市場調査レポート

多発性骨髄腫:世界の治験レビュー

Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 225555
出版日 ページ情報 英文 182 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
多発性骨髄腫:世界の治験レビュー Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014
出版日: 2014年10月31日 ページ情報: 英文 182 Pages
概要

当レポートでは、多発性骨髄腫に関する臨床研究の最新動向について分析し、疾患の概要を初め、G7諸国・BRICS諸国・E7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 多発性骨髄腫
  • 当レポートの構成

各地域における治験

  • 各国の治験件数
    • アジア太平洋地域における治験件数の上位5カ国
    • 欧州における治験件数の上位5カ国
    • 北米における治験件数の上位国
    • 中東・アフリカにおける治験件数の上位5カ国
    • 中南米における治験件数の上位5カ国

BRICS諸国における治験

G7諸国における治験

G7諸国における治験:進行状況別

E7諸国における治験

E7諸国における治験:進行状況別

フェーズ別の治験状況

  • 進行中の治験:フェーズ別

段階別の治験状況

未達成の治験

一定期間に採用された被験者

有望なスポンサー

  • の治験に参加している上位企業

有望な薬剤の比較分析

治験のプロファイル

  • 上位企業の治験の概要
    • Johnson & Johnson
    • Novartis AG
    • Celgene Corporation
    • Merck & Co., Inc.
    • Bristol-Myers Squibb Company
    • Millennium Pharmaceuticals, Inc.
    • Onyx Pharmaceuticals, Inc.
    • Sanofi
    • 武田薬品工業
    • Oncotherapeutics
    • Amgen Inc.
    • Cephalon, Inc.
    • Pfizer Inc.
    • Janssen Biotech, Inc.
    • GlaxoSmithKline plc
    • Innate Pharma SA
    • Korean Multiple Myeloma Working Party
    • Seattle Genetics, Inc.
    • 大塚製薬
    • Gilead Sciences, Inc.
  • 上位大学・研究機関・業印の治験の概要
    • Fred Hutchinson Cancer Research Center
    • The University of Texas M. D. Anderson Cancer Center
    • University of Arkansas
    • Mayo Clinic
    • Memorial Sloan Kettering Cancer Center
    • Sidney Kimmel Comprehensive Cancer Center
    • H. Lee Moffitt Cancer Center & Research Institute
    • Dana-Farber Cancer Institute
    • Masonic Cancer Center
    • Southwest Oncology Group
    • Case Comprehensive Cancer Center
    • Barbara Ann Karmanos Cancer Institute
    • Massachusetts General Hospital
    • University of California, San Francisco
    • PETHEMA
    • City of Hope National Medical Center
    • Stanford University
    • The Cleveland Clinic
    • Duke University
    • Washington University School of Medicine

主要治験の詳細情報

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2386CTIDB

GlobalData's clinical trial report, "Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014" provides data on the Multiple Myeloma (Kahler's Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Myeloma (Kahler's Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Multiple Myeloma (Kahler's Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Multiple Myeloma (Kahler's Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Multiple Myeloma (Kahler's Disease)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Multiple Myeloma (Kahler's Disease)
    • Oct 01, 2014: Innate Pharma Announces Initiation of a Phase I clinical trial of Lirilumab in combination with elotuzumab
    • Sep 25, 2014: Novel Compound Prevents Metastasis of Multiple Myeloma in Mouse Studies
    • Sep 04, 2014: Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma
    • Aug 25, 2014: Patrys Releases Details of PAT-SM6 & Carfilzomib Clinical Trial
    • Aug 11, 2014: Genmab Announces New Phase III Study of Daratumumab in Front Line Multiple Myeloma
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • University of Arkansas
      • Clinical Trial Overview of University of Arkansas
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • Barbara Ann Karmanos Cancer Institute
      • Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Source

List of Tables

  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Multiple Myeloma (Kahler's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014*

List of Figures

  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Multiple Myeloma (Kahler's Disease) to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Multiple Myeloma (Kahler's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Multiple Myeloma (Kahler's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top